KING PHARMACEUTICALS (KG) P/E (2025 - 2026)
KING PHARMACEUTICALS (KG) P/E from May 28, 2025 to Jun 3, 2026. The TTM KING PHARMACEUTICALS (KG) P/E is -2.84. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of KING PHARMACEUTICALS (KG)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.84 | -10.08% |
| 2025 | -3.16 | N/A |
Comparison KING PHARMACEUTICALS (KG) P/E with competitors
KING PHARMACEUTICALS (KG) P/E is -2.84.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| HG | Hamilton Insurance Group Ltd - Class B | 3.47 | -222.07% |
| RNR | RenaissanceRe Holdings Ltd | 4.71 | -265.99% |
| SPNT | SiriusPoint Ltd | 5.26 | -285.32% |
| GLRE | Greenlight Capital Re Ltd - Class A | 6.82 | -340.10% |
| EG | Everest Group Ltd | 6.98 | -345.87% |
| RGA | Reinsurance Group Of America Inc | 12.95 | -556.03% |